Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M122,190Revenue $M49,384Net Margin (%)7.7Altman Z-Score2.2
Enterprise Value $M136,582EPS $4.6Operating Margin %10.0Piotroski F-Score6
P/E(ttm)47.1Beneish M-Score-2.6Pre-tax Margin (%)10.0Higher ROA y-yN
Price/Book5.010-y EBITDA Growth Rate %5.7Quick Ratio0.8Cash flow > EarningsY
Price/Sales2.45-y EBITDA Growth Rate %3.3Current Ratio1.3Lower Leverage y-yN
Price/Free Cash Flow25.8y-y EBITDA Growth Rate %3.7ROA % (ttm)5.2Higher Current Ratio y-yN
Dividend Yield %1.7PEG14.3ROE % (ttm)16.9Less Shares Outstanding y-yY
Payout Ratio %53.0Shares Outstanding M827ROIC % (ttm)9.7Gross Margin Increase y-yY

Gurus Latest Trades with BAYRY

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BAYRYKen Fisher 2015-06-30 Add0.59%$139.35 - $155
($147.22)
$ 147.760%Add 83.74%4,610,296
BAYRYKen Fisher 2015-03-31 Add$130.2 - $155.97
($144.95)
$ 147.762%Add 0.63%2,509,075
BAYRYKen Fisher 2014-06-30 Add0.6%$126.84 - $144.81
($138.38)
$ 147.767%Add 750.48%2,302,369
BAYRYKen Fisher 2014-03-31 Add0.06%$128.3 - $142.7
($135.49)
$ 147.769%Add 217.05%270,713
BAYRYKen Fisher 2013-06-30 Add0.01%$101 - $112.75
($106.88)
$ 147.7638%Add 34.62%84,456
BAYRYVanguard Health Care Fund 2012-09-30 Reduce-0.03%$68.01 - $88.62
($77.6)
$ 147.7690%Reduce 3.71%2,594,656
BAYRYKen Fisher 2012-09-30 Buy 0.02%$68.01 - $88.62
($77.14)
$ 147.7692%New holding72,838
BAYRYKen Fisher 2012-03-31 Sold Out -0.01%$0.04 - $75.15
($59.98)
$ 147.76146%Sold Out0
BAYRYKen Fisher 2011-09-30 Add$49.73 - $84.17
($66.88)
$ 147.76121%Add 24.27%46,440
BAYRYJohn Keeley 2009-06-30 Sold Out -0.01%$47.66 - $59.35
($52.77)
$ 147.76180%Sold Out0
BAYRYKen Fisher 2009-06-30 Sold Out $47.66 - $59.35
($52.77)
$ 147.76180%Sold Out0
BAYRYJohn Keeley 2009-03-31 Buy 0.01%$43.75 - $59.4
($52.7)
$ 147.76180%New holding6,500
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BAYRY is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


BAYRY: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Quarterly/Annual Reports about BAYRY:

    News about BAYRY:

    Articles On GuruFocus.com
    Ken Fisher's most weighted buys in Q2 2015 Jul 28 2015 
    UnitedHealth Group Reports Strong Second Quarter Earnings Results Jul 21 2015 
    Bayer AG Wins Approval On Existing Antibiotic For Plague Treatment May 12 2015 
    Bayer Enters Into Collaboration With Isis For Enhancing Its Drug Portfolio May 07 2015 
    DuPont Eyeing Acquisition To Leverage Its Market Spread Apr 24 2015 
    savings Apr 22 2015 
    Bayer Goes Into Disinvestment Mode Due To Falling Profit Numbers Feb 27 2015 
    Zoetis Will Benefit from Industry Trends Oct 07 2014 
    Baxter Will Remain Diversified and With Competitive Advantages Sep 02 2014 
    Ken Fisher's Top Increaes of the Second Quarter Jul 28 2014 

    More From Other Websites
    Will Regeneron (REGN) Earnings Surprise on Eylea Sales? - Analyst Blog Jul 31 2015
    Bayer (BAYRY) Q2 Revenues Up Y/Y, 2015 Guidance Revised - Analyst Blog Jul 30 2015
    Bayer reports boost in sales, income for 2Q Jul 29 2015
    Bayer Earnings Beat Estimates on Xarelto and Plastics Division Jul 29 2015
    Bayer CEO: No plans to acquire rival Syngenta Jul 29 2015
    Sygenta not our target: Bayer CEO Jul 29 2015
    Bayer significantly improves earnings Jul 29 2015
    Offering integrated solutions and driving partnerships to promote sustainability in potatoes Jul 28 2015
    Not intended for U.S. and UK Media -- Bayer HealthCare Enters Into Collaboration With Sprint... Jul 28 2015
    Glenmark Pharmaceuticals' Finacea generic infringes Bayer patent - court Jul 27 2015
    Boston Scientific (BSX) Earnings Report: Q2 2015 Conference Call Transcript Jul 23 2015
    First appearance under new name -- Covestro premiere at Fakuma -- New developments for automotive... Jul 20 2015
    Bayer AG downgraded by Jefferies Jul 20 2015
    Bayer MaterialScience launches INSQIN® Partner Manufacturer Program Jul 16 2015
    New edition of research, the Bayer Scientific Magazine, published -- Life science research for... Jul 16 2015
    Battery problems delay round-the-world record flight bid -- Bayer MaterialScience supports Solar... Jul 15 2015
    Bayer receives European approval for Gadovist® (gadobutrol) for use in pediatric patients less than... Jul 14 2015
    Regeneron and Sanofi Report Positive Data on Praluent - Analyst Blog Jul 09 2015
    3 Reasons Value Stock Investors Will Love Bayer AG (BAYRY) - Tale of the Tape Jul 08 2015
    Design students discover new creative possibilities with polycarbonate -- Creative material... Jul 03 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK